1.
Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and d-amphetamine in the rat
by IDRIS, N. F
Psychopharmacologia, 2005, Vol.179 (2), p.336-348

2.
A parametric analysis of olanzapine-induced weight gain in female rats
by COOPER, G. D
Psychopharmacologia, 2005, Vol.181 (1), p.80-89

3.
The effects of lithium on cognition: an updated review
by PACHET, Arlin K
Psychopharmacologia, 2003, Vol.170 (3), p.225-234

4.
Zolpidem and zopiclone impair similarly monotonous driving performance after a single nighttime intake in aged subjects
by Bocca, Marie-Laure
Psychopharmacologia, 2010-11-18, Vol.214 (3), p.699-706

5.
Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study
by SILVESTRI, Simone
Psychopharmacologia, 2000, Vol.152 (2), p.174-180

6.
Residual effects of esmirtazapine on actual driving performance: Overall findings and an exploratory analysis into the role of CYP2D6 phenotype
by Ramaekers, J.G
Psychopharmacologia, 2011-01-01, Vol.215 (2), p.321-332

7.
Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers
by ZACNY, James P
Psychopharmacologia, 2003, Vol.170 (3), p.242-254

8.
Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine
by Davoodi, Nima
Psychopharmacologia, 2008-12-04, Vol.203 (4), p.693-702

9.
Distinct temporal phases in the behavioral pharmacology of LSD : dopamine D2 receptor-mediated effects in the rat and implications for psychosis
by MARONA-LEWICKA, Danuta
Psychopharmacologia, 2005, Vol.180 (3), p.427-435

10.
Effects of sertraline on autonomic and cognitive functions in healthy volunteers
by SIEPMANN, Martin
Psychopharmacologia, 2003, Vol.168 (3), p.293-298

11.
The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers
by YOUNG, A. H
Psychopharmacologia, 1999, Vol.145 (3), p.260-266

12.
Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats
by WADENBERG, M.-L. G
Psychopharmacologia, 2000, Vol.150 (4), p.422-429

13.
Attenuation of d-amphetamine self-administration by baclofen in the rat : Behavioral and neurochemical correlates
by BREBNER, Karen
Psychopharmacologia, 2005, Vol.177 (4), p.409-417

14.
Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder : a 4-week placebo-controlled trial
by KECK, P. JR
Psychopharmacologia, 1998, Vol.140 (2), p.173-184

15.
Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia
by Zhang, Xiang Yang
Psychopharmacologia, 2009-06-16, Vol.205 (4), p.647-654

16.
Enadoline, a selective kappa opioid agonist : comparison with butorphanol and hydromorphone in humans
by WALSH, Sharon L
Psychopharmacologia, 2001, Vol.157 (2), p.151-162

17.
Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea
by Steinlechner, Susanne
Psychopharmacologia, 2009-10-13, Vol.207 (4), p.593-597

18.
Study of the addictive potential of modafinil in naive and cocaine-experienced rats
by DEROCHE-GAMONET, V
Psychopharmacologia, 2002, Vol.161 (4), p.387-395

19.
Attenuation of the effects of d-amphetamine on interval timing behavior by central 5-hydroxytryptamine depletion
by Body, S
Psychopharmacologia, 2008-11-19, Vol.203 (3), p.547-559

20.
Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine
by Jong, T.R. de
Psychopharmacologia, 2005, Vol.179 (2), p.509-15
